These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 300395)
21. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor. Fuson EW; Cole AJ; Hubbard RA J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410 [TBL] [Abstract][Full Text] [Related]
22. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC). Christiaansen JE; Burnside SS; Sears DW J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899 [TBL] [Abstract][Full Text] [Related]
23. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes. Kagnoff MF; Campbell S Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425 [TBL] [Abstract][Full Text] [Related]
24. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716 [TBL] [Abstract][Full Text] [Related]
25. Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells. Herberman RB; Bartram S; Haskill JS; Nunn M; Holden HT; West WH J Immunol; 1977 Jul; 119(1):322-6. PubMed ID: 326962 [TBL] [Abstract][Full Text] [Related]
26. Characterization of mononuclear effector cells in human blood. Hersey P; Edwards A; Edwards J Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316 [TBL] [Abstract][Full Text] [Related]
27. The use of antibody-coated liposomes as a target cell model for antibody-dependent cell-mediated cytotoxicity. Geiger B; Schreiber AD Clin Exp Immunol; 1979 Jan; 35(1):149-54. PubMed ID: 428143 [TBL] [Abstract][Full Text] [Related]
28. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. Jewett A; Giorgi JV; Bonavida B J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607 [TBL] [Abstract][Full Text] [Related]
29. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates. Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X; Zhang L; Solomon GF; Bonavida B Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684 [TBL] [Abstract][Full Text] [Related]
31. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements. Perlmann P; Holm G; Stejskal V Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822 [No Abstract] [Full Text] [Related]
32. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198 [TBL] [Abstract][Full Text] [Related]
33. [Antibody-dependent cellular cytotoxicity (ADCC) and its clinical aspects]. Láng I; Fekete B; Kalmár L; Nékám K; Gergely P; Petrănyi G Orv Hetil; 1977 Jul; 118(27):1585-90. PubMed ID: 301626 [No Abstract] [Full Text] [Related]
34. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988 [TBL] [Abstract][Full Text] [Related]
35. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. I. Surface markers and K cell activity after separation of B cells and lymphocytes and Fc-receptors by column fractionation. Pape GR; Troye M; Perlmann P J Immunol; 1977 Jun; 118(6):1919-24. PubMed ID: 325129 [No Abstract] [Full Text] [Related]
36. Lack of association of human "B cell" antigens and Fc receptor activity of antibody-dependent cytotoxic lymphocytes. Miller JL; Humphreys RE; Mann DL J Immunol; 1976 Aug; 117(2):491-6. PubMed ID: 781131 [TBL] [Abstract][Full Text] [Related]
37. Separation of lymphocytes by specific adherence to cellular monolayers containing protein A of Staphylococcus aureus. Ghetie V; Sjöquist J J Immunol; 1975 Sep; 115(3):659-64. PubMed ID: 1097524 [TBL] [Abstract][Full Text] [Related]
38. Functional characterization of mouse T lymphocytes with IgM-Fc receptors. I. Studies on ADCC and helper cell function. Andersson B; Skoglund AC; Rosen A J Immunol; 1979 Nov; 123(5):1936-9. PubMed ID: 385773 [TBL] [Abstract][Full Text] [Related]
39. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments. Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118 [TBL] [Abstract][Full Text] [Related]
40. Selective suppression of immune responses. Regulation of antibody formation and cell-mediated immunity by antibody. Fitch FW Prog Allergy; 1975; 19():195-244. PubMed ID: 56009 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]